Skip to main content
Back to Insight Partners

Insight Partners's Life Science Portfolio

Browse 13 Life Science companies funded by Insight Partners. See funding amounts, founder contacts, and investment details.

Life Science Companies
13
Total Funding in Life Science
$761.0M

Life Science Portfolio Companies (13)

Export
Enterprise SoftwareFinancial ServicesLife ScienceSaaS

Condor Software is a financial intelligence platform that connects clinical, operational, and financial data in real time.

San Diego, United States
March 2026
$24.0M
Series A

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyGeneticsLife Science

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

New York, United States
August 2025
$44.0M
Series C

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical

Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.

Philadelphia, United States
March 2025
$50.0M
Series D

Founder Contacts

41,000+ verified contacts

AnalyticsLife ScienceRisk ManagementSupply Chain Management

Qualifyze provides digital solutions for supply chain risk management in Life Sciences.

Frankfurt, Germany
September 2024
$54.0M
Series B

Founder Contacts

41,000+ verified contacts

Information TechnologyLife ScienceSoftware

Sware provides validation automation platform and managed services programs.

Chelsea, United States
June 2024
$8.0M
Series B

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BioinformaticsClinical TrialsLife Science

Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.

San Francisco, United States
February 2024
$50.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

Berkeley, United States
August 2023
$60.0M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedical

Capacity Bio is a therapeutics company that is focused on mitophagy.

Palo Alto, United States
March 2023
$35.0M
Series A

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

Profluent Bio is an AI-first protein design company creating new proteins and gene-editing tools for medicine, agriculture, and science.

Berkeley, United States
November 2025
$106.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders

San Diego, United States
July 2024
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

Agentic AIArtificial Intelligence (AI)Enterprise SoftwareLife ScienceManufacturingPharmaceutical

The industry's first agentic AI manufacturing platform built for a world beyond paper and legacy MES

Jersey City, United States
March 2023
$65.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

Cambridge, United States
June 2022
$70.0M
Series A

Founder Contacts

41,000+ verified contacts

Life ScienceSoftware

Insightful Science provides software designed to support scientists with research and development procedures.

San Diego, United States
December 2021
$95.0M
Undisclosed

Founder Contacts

41,000+ verified contacts

Explore Insight Partners's Full Portfolio

View all companies funded by Insight Partners across every industry and funding stage.

View Full Insight Partners Portfolio